These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4016034)

  • 21. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood and total fluid content of menstrual discharge.
    Fraser IS; McCarron G; Markham R; Resta T
    Obstet Gynecol; 1985 Feb; 65(2):194-8. PubMed ID: 3969232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of pregnancy-associated endometrial alpha 2-globulin (alpha 2-PEG) during normal menstrual and combined oral contraceptive cycles and relationship to immunohistological localization.
    Wood PL; Walker RA; Bell SC
    Hum Reprod; 1989 Feb; 4(2):140-6. PubMed ID: 2918066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menstruation in women with normal or artificially controlled cycles.
    Callard GV; Litofsky FS; DeMerre LJ
    Fertil Steril; 1966; 17(5):684-8. PubMed ID: 5918615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Contraceptive Pill Alters Acute Dietary Protein-Induced Thermogenesis in Young Women.
    Duhita MR; Schutz Y; Montani JP; Dulloo AG; Miles-Chan JL
    Obesity (Silver Spring); 2017 Sep; 25(9):1482-1485. PubMed ID: 28712125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China].
    Caiyan W; Wen D; Qinping L; Huan S; Ziyan H; Liangdan T; Zheng'ai X; Yufeng L; Shulan Z; Baihua D; Xiaoyan X; Mulan R; Xiaomao L; Youdi X; Zhisong M; Meiqing X; Hongyu W; Zirong H
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):355-9. PubMed ID: 25030732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal cytology in women using oral contraceptives.
    Katira V; Dayal SS
    J Anat Soc India; 1987 Aug; 36(2):94-100. PubMed ID: 12283369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended and continuous combined contraceptive regimens for menstrual suppression.
    Jacobson JC; Likis FE; Murphy PA
    J Midwifery Womens Health; 2012; 57(6):585-592. PubMed ID: 23217068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Triella: a French multicenter double blind clinical study].
    Castaigne JP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations.
    Demacker PN; Schade RW; Stalenhoef AF; Stuyt PM; van't Laar A
    Br Med J (Clin Res Ed); 1982 Apr; 284(6324):1213-5. PubMed ID: 6803905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tissue-type plasminogen activator in plasma of women using oral contraceptives and in normal women during a menstrual cycle.
    Jespersen J; Kluft C
    Thromb Haemost; 1986 Jun; 55(3):388-9. PubMed ID: 3092396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen variation and resting left ventricular structure and function in young healthy females.
    George KP; Birch KM; Jones B; Lea R
    Med Sci Sports Exerc; 2000 Feb; 32(2):297-303. PubMed ID: 10694110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contraception and subsequent fertility. Results of a retrospective study].
    Spira N; Spira A; Schwartz D
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):353-8. PubMed ID: 12280206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
    Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE; Mesure R
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.